Back to all articles

UK Launches £500M Sovereign AI Fund to Operate Like a VC Inside Government

Michael Schneider
8 min read
UK Launches £500M Sovereign AI Fund to Operate Like a VC Inside Government

TL;DR

The UK government has launched a £500 million Sovereign AI Fund that will operate as a standalone venture-style unit inside the Department for Science, Innovation and Technology, chaired by Balderton Capital partner James Wise. The first investment is an equity cheque into AI infrastructure startup Callosum, accompanied by six other UK and UK-linked AI companies that receive fully-funded access to the AIRR supercomputer plus right-of-first-refusal rights on future rounds. A separate £282 million funding call has been opened for datasets, foundation models, and compute infrastructure.

Key Takeaways

The UK is finally running a government fund like a VC, not a grants office. The Sovereign AI Unit is structured to make real equity investments, sit on cap tables, hold ROFR on follow-on rounds, and compete commercially rather than back applicants through grant committees. Pulling James Wise from Balderton to chair it signals the Treasury wants actual underwriting discipline, not civil service consensus.

Compute is being weaponised as an LP-style commitment. Six of the seven first cohort startups are getting up to one million AIRR GPU hours each, effectively a multi-million pound compute grant with no dilution but a ROFR attached. This gets around the main bottleneck for UK AI founders and builds equity exposure in one move. It is a more creative instrument than almost anything in European AI policy.

The cohort is smaller and sharper than expected. Callosum (AI infrastructure), Prima Mente (foundation models for biology and neuroscience), Doubleword (inference optimisation), Cosine (sovereign AI for defence and regulated sectors), Cursive (generative AI foundation models from DeepMind alumni), Odyssey (world models), and Twig Bio (synthetic biology and biomanufacturing). These are deliberately picked to avoid overlap with US frontier labs and focus on infrastructure, defence, and bio applications where sovereignty actually matters.

£500m is small by US standards and that is the point. The fund does not aim to out-spend a16z or Andreessen's defence push. It aims to be the most active UK seed-to-Series-B lead for sovereign AI companies, use ROFR and compute as force multipliers, and unlock private UK and sovereign capital to follow on.

Fund Overview

Fund Name: Sovereign AI Unit / Sovereign AI Fund
Fund Size: £500m initial capitalisation, plus separate £282m R&D funding call for datasets, foundation models, and compute
Stage: Equity investments across seed to Series B for first cohort; flexible mandate for follow-ons
Check Size: Not publicly disclosed per company, but implied range based on first cohort is roughly £5m to £30m equity plus compute
Geography: UK-headquartered companies and UK-linked founders, with some flexibility for British-founded teams based abroad
Focus: Sovereign AI capabilities, AI infrastructure, foundation models, defence and regulated-sector AI, biological foundation models and synthetic biology
Key LPs: HM Treasury via DSIT; structured to invite private co-investment on deals

Why This Fund Matters

Government venture vehicles have a long and usually embarrassing track record. The UK Future Fund in 2020 to 2022 deployed around £375m of convertible loans to startups hit by the pandemic, but it was broadly a liquidity support programme rather than a strategic capital allocator. British Patient Capital invests into funds rather than companies. Innovate UK writes grants. None of these vehicles has been structured to hold equity in a handful of strategic AI companies and compete credibly with private lead investors.

Sovereign AI is different because it is built to take cap table positions, hold ROFR on future rounds, and bundle compute access as part of the commitment. That is unusual enough that even seasoned UK VCs have been openly surprised by the structure. Combining equity with AIRR GPU hours is closer to the way AWS and Azure have historically used credits to secure strategic AI relationships than anything a European government has previously done.

The political backdrop matters. UK AI startups raised around £6 billion in venture capital in 2025, but a large share of those companies ended up with US lead investors, US corporate partners, and increasingly, US domicile. Ministers have been explicit that the Sovereign AI Fund is designed to slow that drift and keep the equity upside of strategically significant AI companies on the UK cap table.

The other question this fund is quietly answering is who underwrites national security AI in the UK. With Cosine (defence and regulated sectors) in the first cohort and the broader Sovereign AI remit spanning biological foundation models and infrastructure, the unit is starting to look like a dual-use vehicle that can fund AI relevant to MOD, NHS, and GCHQ without having to route through classified procurement channels.

The Team

The Sovereign AI Unit is chaired by James Wise, a partner at Balderton Capital since the early 2010s, with a public portfolio that includes consumer and infrastructure bets across Europe. He remains at Balderton while leading the Sovereign AI Fund, which is a deliberate signal that the unit wants a practising VC running it rather than a civil servant. The operational team is being built inside DSIT, with support from the AI Security Institute and secondees from Treasury.

Technology Secretary Liz Kendall launched the fund and first cohort on April 17, 2026, framing it as the start of a sustained government effort to build UK AI champions. Ministerial quotes have emphasised both commercial discipline (equity, not grants) and sovereignty (keeping critical AI capability in UK hands).

Early Portfolio

Callosum takes the first equity investment and is focused on AI infrastructure. Prima Mente, Doubleword, Cosine, Cursive, Odyssey, and Twig Bio round out the first cohort with fully funded compute packages of up to 1 million AIRR GPU hours each plus ROFR on future rounds. Cursive is particularly notable because it is led by DeepMind alumni and is attempting to build UK-based generative foundation models. Twig Bio anchors the synthetic biology corner. Odyssey is UK-linked despite being California-based and is a signal that the unit is willing to back diaspora founders.

What This Means for Founders

UK AI founders who fit the sovereignty thesis now have a credible non-US lead investor that can deliver equity, compute, and fast-tracked visas for senior hires in under a working day. For companies burning significant capital on cloud GPUs, the compute-plus-equity-plus-ROFR package is arguably more valuable than a pure equity cheque at a comparable valuation. Founders should model what a fully funded 1 million GPU-hour allocation actually means for runway extension and the cost of training experiments before negotiating the equity component.

The less obvious benefit is procurement access. Sovereign AI portfolio companies get structured access to UK government data and are being positioned as preferred suppliers for AI services across Whitehall. For infrastructure, defence, and regulated-sector AI companies, that procurement pipeline is a bigger strategic prize than the equity investment itself.

Fund Momentum Take

This is the most interesting sovereign venture structure in Europe right now and the details matter more than the headline number. The combination of equity, ROFR, compute-as-commitment, and procurement access is a model that other European governments will likely copy within 12 to 18 months. Germany, France, and the Netherlands have all been circling similar ideas with less conviction.

The risks are execution risks, not design risks. Government venture vehicles fail when political cycles change, when chairs get replaced with people who do not understand cap tables, or when the civil service overrules individual investment decisions. The Sovereign AI Fund needs to survive at least one change of government and at least one underperforming vintage before it can be called a success. James Wise's continued involvement is critical to that.

Our bet is that within three years the Sovereign AI Fund will be the single most active UK-led seed-to-Series-B investor in sovereign AI, that it will crowd in rather than crowd out private capital, and that one or two of the first cohort companies will be meaningful UK unicorns. Our concern is that £500m is too small for the stated ambition and that it will need a top-up within 24 months, most likely as part of the next Spending Review.

Frequently Asked Questions

Is the Sovereign AI Fund a real venture capital fund?
It is structured as a standalone investment unit inside DSIT that makes equity investments, holds ROFR on follow-on rounds, and operates more like a traditional VC than a grants programme. It is not a private fund with external LPs, but it behaves functionally like one.

Who runs it?
James Wise, a partner at Balderton Capital, chairs the unit while continuing at Balderton. The operational team is being built inside DSIT, supported by the AI Security Institute. Technology Secretary Liz Kendall is the sponsoring minister.

What kinds of companies will it back?
Strategically important UK AI companies, with initial emphasis on AI infrastructure, foundation models, defence and regulated-sector AI, biological foundation models, and synthetic biology. The first cohort of seven companies reflects that split.

What is the compute component?
Six of the first seven cohort companies receive fully funded access to the UK AI Research Resource (AIRR) supercomputer of up to 1 million GPU hours each. This sits alongside the equity investment into Callosum as a separate instrument used to secure strategic relationships without dilution.

How does this differ from the UK Future Fund?
The Future Fund was a time-limited convertible loan programme to support startups through the pandemic and did not hold strategic equity positions. Sovereign AI is structured to hold equity long-term, sit on cap tables, bundle compute access, and compete directly with private lead investors for strategically important deals.


Have a fund closing to announce? Submit your fund here.

Need help raising capital? Check out our Fundraising Advisory services.

Share